Members log in

Remember me

Do not refresh my screen on timeout

close

News

Valproate and childbearing potential: new regulations

Read More

Events

ABN/SBNS Joint meeting 19-21 September 2018 - registration now open. Abstract deadline extended to 25 June

Read More

News

New guidelines on the prevention of Listeria infection after alemtuzumab treatment

19 May 2017 | ABN

We have received several reports of Listeria after alemtuzumab treatment of multiple sclerosis and the ABN Multiple sclerosis & neuroinflammation Advisory Group has produced some guidance on how to prevent this.

Please click here to read the full guidelines.

News

Valproate and childbearing potential: new regulations

Read More

Events

ABN/SBNS Joint meeting 19-21 September 2018 - registration now open. Abstract deadline extended to 25 June

Read More